Kristi Ann Matus
CIK 1543504 · EVP and CFAO · last filed 2026-10-05
Kristi Ann Matus is an EVP and CFAO who has filed 53 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing, for OSG, was dated Oct 5, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions. 13 SEC filings were submitted jointly with ATHENAHEALTH INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EQH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
40 WALL STREET, 55TH FLOOR
NEW YORK, NY 10005
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OSG | Director | — | $4.80 | — | $0 | 4 | 2026-10-05 |
| UNMA | Director | 2,191 | $20.12 | $44.1K | $0 | 1 | 2026-05-28 |
| CRNC | Director | 54,737 | $8.32 | $455.4K | -$399.6K | 9 | 2026-02-13 |
| OCTAVE SPECIALTY GROUP INC (AMBC) Delisted | Director | 48,179 | $8.85 | $426.4K | $100.7K | 13 | 2025-10-02 |
| EQH | Director | 10,615 | $53.58 | $568.8K | -$774.0K | 7 | 2023-03-24 |
| AB | Director | 20,254 | $35.28 | $714.6K | $0 | 3 | 2022-05-23 |
| ATHENAHEALTH INC (ATHN) Delisted | EVP and CFAO | 34,316 | $9.59 | $329.1K | -$533.8K | 12 | 2016-05-03 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-05 | OSG | Grant (A) | — | $0 | EDGAR |
| 2026-07-07 | OSG | Grant (A) | — | $0 | EDGAR |
| 2026-05-28 | UNMA | Grant (A) | +2,191 | $0 | EDGAR |
| 2026-04-02 | OSG | Grant (A) | — | $0 | EDGAR |
| 2026-02-13 | CRNC | Grant (A) | +12,968 | $130 | EDGAR |
| 2026-01-05 | OSG | Grant (A) | — | $0 | EDGAR |
| 2025-10-02 | OCTAVE SPECIALTY GROUP INC (AMBC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-09-30 | OCTAVE SPECIALTY GROUP INC (AMBC) Delisted | Conv (C) | +39,179 | $0 | EDGAR |
| 2025-07-01 | OCTAVE SPECIALTY GROUP INC (AMBC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | OCTAVE SPECIALTY GROUP INC (AMBC) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.